Cargando…
Janus Dendrimers to Assess the Anti-HCV Activity of Molecules in Cell-Assays
The use of nanocarriers has been revealed as a valid strategy to facilitate drug bioavailability, and this allows for expanding the drug libraries for the treatment of certain diseases such as viral diseases. In the case of Hepatitis C, the compounds iopanoic acid and 3,3′,5-triiodothyroacetic acid...
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695217/ https://www.ncbi.nlm.nih.gov/pubmed/33171841 http://dx.doi.org/10.3390/pharmaceutics12111062 |